The growth in this market is driven by high sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals, the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.
The report High-performance Liquid Chromatography (HPLC) Market is projected to reach USD 5.7billion by 2025 from USD 4.5billion in 2020, at a CAGR of 4.6% during the forecast period. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209 Market Segmentation: - Based on the product, the market was divided into instruments, consumables, and accessories. The instrument market is subjected to account for the largest share in the HPLC market and consumables to growth at the highest rate during the forecast period. The need to analyze compounds in trace concentration and the extensive use of the system in forensic institutes and industries such as pharmaceuticals, food, nutraceuticals, cosmetics, and environmental testing calls for growth of the segment. Based on the application, the HPLC market is divided into clinical research, diagnostics, forensics, and other applications. Clinical research is subjected to grow at the highest rate in the forecast period. A rise in pharmaceutical and biotechnological research fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is said to drive the market. Regional Analysis: - North America is expected to account for the largest share of the global HPLC market. Market growth in this region is driven primarily by the increase in R&D funding, the growing number of preclinical activities by CROs &pharmaceutical companies, and the increasing food & agricultural industry in Canada. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=117899209 Top Key Players:- The global HPLC market is well established owing to the dominance of prominent market players, such as Waters (US), Agilent (US), Shimadzu (Japan), Thermo Fisher (US), PerkinElmer (US), GE Healthcare (US), Bio-Rad (US), Merck Millipore (Germany), Hitachi (Japan), Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US), Hamilton Company (US), SIELC (US), Orochem (US), YMC Co. Ltd. (Japan), Restek (US), Trajan Scientific (Australia), and Tosoh Bioscience LLC (Japan).
0 Comments
Market growth is driven mainly by factors such as increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market.
The global Stem Cell Therapy Market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48 Market Segmentation: - The adipose tissue-derived MSCs segment accounted for the largest share of the cell source segment in the stem cell therapy market in 2020. Based on the cell source from which stem cells are obtained, the global stem cell therapy market is segmented into four sources. These include adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources (which includes human corneal epithelium stem cells, peripheral arterial-derived stem cells, and induced pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs accounted for the markets largest share due to their increasing utilization in treating inflammatory diseases and wounds & injuries. There are several associated advantages, such as ease of harvesting stem cells by minimally invasive methods, simplicity of the isolation procedure, and better quality & proliferation capacity of adipose tissue-derived stem cells. The musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment in the stem cell therapy market in 2020 Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications (which include ocular diseases, fat loss, and peripheral arterial diseases). In 2020, the musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment. The large market share of this segment is attributed to the increasing prevalence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration. Regional Analysis: - The Asia Pacific region is the fastest-growing region of the stem cell therapy market in 2020. The Asia Pacific region is estimated to grow at the highest CAGR in the stem cell therapy market during the forecast period. Some of the major factors fueling the growth of the APAC market include regulatory approvals and guidelines for product approvals and the presence of major stem cell players in countries such as South Korea, Japan, India, and Australia. Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48 Top Key Players: - Key players in the stem cell therapy market include Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US). Increasing research activities in the field of nanotechnology, rising investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries are fueling the growth of the market. Moreover, increasing government support for nanotechnology research and the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this market.
The Particle Size Analysis Market is projected to reach USD 465 million by 2025 from USD 356 million in 2020, growing at a CAGR of 5.5% during the forecast period. Ask for PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 Market segmentation: - Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, and other technologies. The laser diffraction segment accounted for the largest share of the particle size analysis market in 2019, driven by the growing initiatives to create awareness about laser diffraction, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns. Based on type, the imaging market is segmented into two major types—dynamic imaging and static imaging. The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth during the forecast period by technology. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology. Recent Developments:
Regional Analysis: - The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region accounted for the largest share of the particle size analysis market in 2019. Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=74084833 Top Key Players: - The major players operating in the particle size analyzers market are Malvern Panalytical (UK), HORIBA (Japan), Beckman Coulter, (UK), MICROTRAC MRB, (US), Izon Science (UK), Micromeritics Instrument Corporation (US), Shimadzu Corporation (Japan), Sympatec (Germany), Anton Paar (Austria), TSI (US), Bettersize Instruments (China), FRITSCH (Germany), Brookhaven Instruments, (US), LS Instruments AG (Switzerland), and AimSizer (China). Growth in this market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research.
The global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883 Market Segmentation: - By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement. Based on the neurostimulation and neuromodulation application, the nerve regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period. Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. Recent Developments: -
Regional Analysis: - The nerve repair market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the nerve repair and regeneration industry, followed by Europe. Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=883 Top Key Players: - Some of the major players operating in the global nerve repair market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan). Proficiency testing forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the growth of the proficiency testing market, globally. Also, the stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth.
The Laboratory Proficiency Testing Market is projected to reach USD 1,103 million by 2024 from USD 800 million in 2019, at a CAGR of 6.6% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949 The cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by industry, during the forecast period In the laboratory proficiency testing market, by industry, the cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is primarily driven by the legalization of medical cannabis, growing number of cannabis testing laboratories, rising awareness about the medical use of cannabis, and the increasing availability of analytical testing instruments and software. The proficiency testing market for chromatography is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by technology, during the forecast period In the laboratory proficiency testing market, by technology, the chromatography segment is expected to grow at the highest CAGR during the forecast period. Chromatography is used to carry out complicated separations like amino acid sequencing or pollutant separations, based on differential partitioning between the mobile and stationary phase. The advantages associated with chromatographic testing, such as the increased safety, reliability, and transparency of the pharmaceutical supply chain by testing the identity, strength, purity, quality, and potency of a drug product, and the growth in the pharmaceutical industry as a whole are the major factors driving the growth of this segment. The Asia Pacific region holds high growth potential in the laboratory proficiency testing market The Asia Pacific is considered to be the most attractive regional market for laboratory proficiency testing owing to the large base of manufacturers and research laboratories in the region. Also, the growing scientific base and research capabilities in several Asian countries; growth of the Asian pharmaceutical, food, and biologics markets; and the large base of CROs in the region are some of the other major factors driving market growth in the region. Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=144227949 The prominent players operating in the global laboratory proficiency testing market are LGC Limited (UK), Bio-Rad Laboratories (US), Randox Laboratories (UK), Merck (Germany), College of American Pathologists (US), American Proficiency Institute (US), Waters Corporation (US), QACS (Greece), FAPAS (UK), AOAC (US), Phenova Inc. (US), Weqas (Cardiff), Advanced Analytical Solutions, LLC (UK), Bipea (France), Absolute Standards Inc. (US), and NSI Lab Solutions (US). Market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the HTS market.
The global High-Throughput Screening (HTS) Market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period. Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950 Market Segmentation: - The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019. On the basis type ofproduct & service, the high-throughput screening market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research. The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019. Based on application, the high-throughput screening market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure. Key Market Drivers: – 1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies 2 Government Funding and Venture Capital Investments 3 Increasing R&D Spending 4 Technological Advancements in the HTS market Regional Analysis: -In 2019, Asia Pacific region accounted for the fastest-growing region of the high-throughput screening market. It is also estimated to grow at the highest CAGR in the high-throughput screening market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region. Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950 Top key Players: - Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg). Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. The base year considered for the study is 2019, while the forecast period is 2020 to 2025.
The report European Medical Devices Market is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=241277169 Market Segmentation: - By device, orthopedic devices segment accounted for the largest share of the European Medical Device Market in 2019 Based on device type, the market has been segmented into orthopedic devices, diagnostic imaging systems, endoscopy devices, ophthalmic devices, interventional cardiology devices, cardiac monitoring and cardiac rhythm management devices, respiratory care devices, ventilators, anesthesia monitoring devices, dialysis devices, and diabetic care devices. The orthopedic devices segment accounted for the largest share of the European medical devices market in 2019. The growing incidence of orthopedic disorders such as arthritis, osteoporosis, soft-tissue injuries, and fractures among the elderly population is expected to drive the demand for orthopedic devices in Europe. The Hospitals and clinical care settings segment is expected to witness the highest growth rate in the European medical devices market, by end-user, during the forecast period Based on end-user, the European medical devices market is segmented into hospitals and clinical care settings and home care settings. Hospitals and clinical care settings were the largest end-users of medical devices in Europe in 2019. This can largely be attributed to the financial capabilities of hospitals to purchase expensive devices as well as the availability of trained professionals in hospitals to operate these devices. Regional Analysis: - Germany accounted for the largest share of the European medical device market in 2019. The rising geriatric population and the presence of strong healthcare infrastructure in the country are the major factors that are driving the demand for medical devices in Germany. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=241277169 Key Market Players: - The prominent players in the global European medical device market are Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Abbott (US), Medtronic (Ireland), Stryker (US), Boston Scientific (US), Asahi Kasei Medical (Japan), B. Braun (Germany), Baxter International, Inc. (US), ResMed (US), Masimo (US), and KARL STORZ (Germany).. The growth of this market is primarily driven by the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.
The report Animal Growth Promoters and Performance Enhancers Market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9% during the forecast period. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167 Market Segmentations: -. Based on type, the animal growth promoters market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2018. On the basis of animal type, the Animal Performance Enhancers Market is segmented into poultry, swine, livestock, aquaculture, and other farm animals (equine, rabbit, camel, deer, yak, and geese). In 2019, the poultry segment accounted for the largest share of the animal growth promoters and performance enhancers market. Critical questions answered in the Report: -
Regional Analysis: - In 2019, the Asia Pacific region accounted for the largest market share of 36.7%, followed by North America (26.1%) in 2018. The largest share of the Asia Pacific region is attributed to the strong animal products industry in this region, high population (generating greater domestic meat demand), a comparatively relaxed regulatory scenario, and government efforts to encourage animal producers. Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=137134167 Key Players: - The key players in the global animal performance enhancers market are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N.V. (Germany), Vetoquinol (France), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Novus International Inc. (US), Associated British Foods (ABF) plc (UK), Alltech Inc. (US), ERBER AG (UK), Archer-Daniels-Midland Company (US), Phibro Animal Health Corporation (US), Kemin Industries (US), SHV (Nutreco) (UK), BASF SE (UK), Lallemond Inc. (Canada), Bluestar Adisseo Company (France), Evonik Industries AG (UK), and Land O Lake Inc.(US). The growth of the market is attributed favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population. Increasing research and development activities and increase in diabetes-related health expenditure in emerging economies are expected to offer significant growth opportunities for manufacturers in the coming years.
The Insulin Delivery Devices Market is expected to reach USD 17.8 billion by 2021 from USD 11.5 billion in 2016, at a CAGR of 9.1% during the forecast period. Ask for PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107632092 Key Market Drivers:- 1 Growing Diabetic Population 2 Technological Advancements in Insulin Delivery Devices 3 Favorable Reimbursement Environment and Government Support in Selected Countries 4 Conferences, Meetings, and Congresses to Create Awareness About Insulin Delivery Devices Market Segmentation:- Based on type, the insulin delivery devices market is categorized into pens, pumps, pen needles, syringes, and others (insulin inhalers, transdermal patches, and insulin jet injectors, among others). In 2016, the pens segment is expected to command the largest share of the insulin delivery devices market. The pens segment is further divided into reusable and disposable pens. The reusable pens segment is estimated to command the largest share of the insulin pens market in 2016. This large share can be attributed to lower price compared to disposable pens; availability of reimbursement in selected countries, and increasing adoption of insulin pens in the Asia-Pacific region. By end user, the insulin delivery devices market is segmented into patients/homecare and hospitals & clinics. The patients/homecare segment is estimated to command the largest share of the market in 2016 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be primarily attributed to the increasing diabetic population and rising healthcare expenditure. Regional Analysis: - In 2016, North America is expected to account for the largest share of the global insulin delivery devices market. North America’s leadership position in the market can be attributed to the rising prevalence of diabetes and favorable reimbursement scenarios in the US and Canada, awareness activities, venture capital investments and issuance of IPOs in the US, and regulations for the usage of safety-engineered needles in Canada. Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=107632092 Top Key Players :- The insulin delivery devices market is highly competitive with the presence of several small and big players. Some of the players in the insulin delivery devices market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (US), Tandem Diabetes Care, Inc. (US), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (US), and Insulet Corporation (US). The growing target patient population and the rising focus on minimally invasive surgical procedures over conventional surgery are the major factors driving the growth of this market.
The report Catheters Market is Projected to Reach USD 24.2 Billion by 2025, at a CAGR of 8.7% from 2020 to 2025 Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6247803 In 2019, the cardiovascular catheters segment accounted for the largest share of the market. On the basis of type, the global catheters market is segmented broadly into cardiovascular, urological, intravenous, neurovascular, and specialty catheters. Cardiovascular catheters commanded the largest share of the catheters market in 2019 and are expected to grow at the highest CAGR during the forecast period. This is primarily attributed to factors such as the high incidence of CVD, the growing geriatric population, and increasing awareness regarding early diagnosis. These factors have resulted in an increase in cardiovascular surgeries, which positively impacts the cardiovascular catheters market. Hospitals to be the largest end users of catheters Based on end user, the catheters market is segmented into hospitals, long-term care facilities, diagnostic imaging centers, and other end users. In 2019, hospitals were the largest end users of catheters. This segment is expected to grow at the highest CAGR, majorly due to the high volume of target procedures performed in hospitals. The presence of big cath labs and electrophysiology labs in hospitals and a growing patient population are other key drivers of this market. The emergence of advanced diagnostic imaging catheters, coupled with the demand for minimally invasive procedures, is accelerating the adoption of catheters in hospitals. North America was the largest regional market for catheters in 2018 The catheters market has been divided into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global catheters market in 2019. This is attributed to various factors such as the large number of target procedures performed in the region, the presence of a well-established healthcare system, and investments by hospitals to upgrade & expand operating capabilities. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=6247803 Top Key Players:- The prominent players operating in this market include Medtronic (Ireland), Edwards Lifesciences Corporation (US), Teleflex Incorporated (US), Abbott (US), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), ConvaTec Group (UK), Coloplast (Denmark), Johnson & Johnson Services (US), Terumo Corporation (Japan), Hollister Incorporated (US), Stryker (US), Cook Medical (US), and Merit Medical Systems (US). |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |